An evidence-based estimate of the appropriate rate of utilization of radiotherapy for cancer of the cervix

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 3, 2005, Pages 812-827

  Usmani, Nawaid ^a,b   Foroudi, Farshad ^c   Du, Jenny ^a   Zakos, Celine ^a   Campbell, Holly ^b   Bryson, Peter ^b   Mackillop, William J ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b Cancer Centre of Southeastern Ontario   (Canada)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Cervical cancer; Needs assessment; Radiotherapy; Treatment guidelines

Indexed keywords

BIOLOGICAL ORGANS; EPIDEMIOLOGY; ONCOLOGY; PLANNING; SURVEYS; TUMORS;

CERVICAL CANCER; EVIDENCE-BASED ESTIMATE; NEEDS ASSESSMENT; TREATMENT GUIDELINES;

RADIOTHERAPY;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; MEDICAL PRACTICE; NORTH AMERICA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

EID: 25844437512     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.03.025     Document Type: Article

References (89)

1. National Cancer Institute of Canada Canadian Cancer Statistics 2003 2003 Canadian Cancer Society Toronto, Canada
2. Intersociety Council for Radiation Oncology Radiation oncology in integrated cancer management. Report to the Director of the National Cancer Institute 1991 American College of Radiology Washington, DC
3. Ontario Cancer Treatment and Research Foundation A plan for radiation treatment, province of Ontario, 1995-2000 1995 OCTRF Toronto, Ontario
4. W. Duncan, D. Jenkin The Radiation Oncology Commission A Report to the Ontario Treatment and Research Foundation, and the Ontario Cancer Institute 1990 OCTRF Toronto, Ontario
5. J.E. Frodin, E. Jonsson, T. Moller Radiotherapy in Sweden A study of present use in relation to the literature and an estimate of future trends Acta Oncol 35 1996 967 979
6. F.J. Cleton, J.W.W. Coebergh Cancer in the Netherlands 1991 Kluwer Academic Dordrecht
7. W.J. Mackillop, P.A. Groome, J. Zhang-Salomons Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol 15 1997 1261 1271
8. W.J. Mackillop, P. Dixon, Y. Zhou Variations in the management and outcome of non-small cell lung cancer in Ontario Radiother Oncol 32 1994 105 115
9. J.W. Denham How do we bring an acceptable level of radiotherapy services to a dispersed population? Australas Radiol 39 1995 171 173
10. K. Lote, T. Moller, E. Nordman Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987 Acta Oncol 30 1991 555 561
11. S. Tyldesley, C. Boyd, K. Schulze Estimating the need for radiotherapy for lung cancer An evidence-based epidemiological approach Int J Radiat Oncol Biol Phys 49 2001 973 985
12. F. Foroudi, S. Tyldesley, H. Walker An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer Int J Radiat Oncol Biol Phys 53 2002 1240 1253
13. F. Foroudi, S. Tyldesley, L. Barbera Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer Int J Radiat Oncol Biol Phys 55 2003 51 63
14. F. Foroudi, S. Tyldesley, L. Barbera An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer Int J Radiat Oncol Biol Phys 56 2003 1295 1307
15. J. Wright Health needs assessment in practice 1998 BMJ Publishing Group London
16. C. Sanderson, D. Hunter, M. McKee Limitations of epidemiologically based needs assessment The case of prostatectomy Med Care 35 1997 669 685
17. A.H. Cuyler Need and that national health service Economics and social choice 1976 Rowman and Littlefield Princeton, NJ
18. The American Heritage Dictionary of the English Language 3rd ed. 1996 Houghton Mifflin Boston
19. National Cancer Institute. Cancer.gov:PDQ cancer information summaries: cervical cancer: treatment. Monograph on line. Available at: http://www.cancer.gov/cancerinfo/pdq/treatment/cervical/healthprofessional/. Accessed August 2004.
20. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: cervical cancer. Version 1.2002. Monograph on line. Available at: http://www.nccn.org/physician_gls/index.html. Accessed August 2004.
21. B. Greer, W. Koh ACOG Practice Bulletin Diagnosis and treatment of cervical carcinomas Obstet Gynecol 99 2002 855 867
22. Society of Gynecologic Oncologists practice guidelines Cervical cancer Oncology 12 1998 134 138
23. National Health Service Executive Improving outcomes in gynaecological cancers The manual 1999 National Health Service Wetherby, UK
24. M. Resbeut, E. Fondrinier, B. Fervers Carcinoma of the cervix Br J Cancer 84 Suppl. 2 2001 24 30
25. H. Lee Moffitt Cancer Center & Research Institute. Clinical practice guidelines for gynecologic cancers. Monograph on line. Available at: http://www.moffitt.usf.edu/pubs/ccj/v3n4/dept2.html. Accessed August 2004.
26. Cancer Care Ontario. Primary treatment for locally advanced cervical cancer: concurrent platinum-based chemotherapy and radiation. Monograph on line. Available at: http://www.cancercare.on.ca/ccopgi/. Accessed August 2004.
27. BC Cancer Agency. Uterine cancer. Monograph on line. Available at: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Gynecology/ UterineCervix1of2/default.htm. Accessed August 2004.
28. M.D. Anderson Cancer Center. Cervical cancer. Monograph on line. Available at: http://utm-notes-b2.mdacc.tmc.edu/mdacc/cm/cwtguide.nsf/LuHTML/ Sidebar1. Accessed August 2004.
29. M. Friedlander Guidelines for the treatment of recurrent and metastatic cervical cancer Oncologist 7 2002 342 347
30. Federation Internationale de Gynecologie et d'Obstetrique (FIGO) Committee on Gynecologic Oncology FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers Int J Gynecol Obstet 20 2000 209 262
31. P.S. Braly, A.S. Lichter, D.K. Ash Cervical cancer NIH Consens Statement 14 1996 1 38
32. S. Nag, C. Chao, B. Erickson The American Brachytherapy Society Recommendations for low-dose-rate brachytherapy for carcinoma of the cervix Int J Radiat Oncol Biol Phys 52 2002 33 48
33. D.L. Sackett Rules of evidence and clinical recommendations on the use of antithrombotic agents Chest 95 Suppl. 2 1989 2S 4S
34. D.M. Eddy A manual for assessing health practices and designing practice policies 1992 American College of Physicians Philadelphia
35. A.B. Nattinger, T.L. McAuliffe, M.M. Schapira Generalizability of the surveillance, epidemiology, and end results registry population Factors relevant to epidemiologic and health care research J Clin Epidemiol 50 1997 939 945
36. E.A. Clarke, L.D. Marrett, N. Kreiger Cancer registration in Ontario A computer approach O.M. Jensen D.M. Parkin R. Maclennan Cancer registration principles and methods 1991 International Agency for Research on Cancer Lyons, France 246 257
37. Y.M.M. Bishop, S.E. Fienberg, P.W. Holland Discrete multivariate analysis Theory and practice 1975 The MIT Press Cambridge, MA
38. D.A. Dillman Mail and internet surveys The tailored design method 2nd ed. 1999 Wiley New York
39. E.C. Gonzalez, J.M. Ferrante, D.J. Van Durme Comorbid illness and the early detection of cancer Southern Med J 94 2001 913 920
40. J.F. Peipert, C.K. Wells, P.E. Schwartz Prognostic value of clinical variables in invasive cervical cancer Obstet Gynecol 84 1994 746 751
41. M.G. del Carmen, F.J. Montz, R.E. Bristow Ethnic differences in patterns of care of stage 1A1 and stage 1A2 cervical cancer A SEER database study Gynecol Oncol 75 1999 113 117
42. P.R. Morgan, M.C. Anderson, C.H. Buckley The Royal College of Obstetricians and Gynaecologists micro-invasive carcinoma of the cervix study Preliminary results Br J Obstet Gynaecol 100 1993 664 668
43. P. Kolstad Follow-up study of 232 patients with stage IA1 and 411 patients with stage 1A2 squamous cell carcinoma of the cervix (microinvasive carcinoma) Gynecol Oncol 33 1989 265 272
44. E. Burghardt, F. Girardi, M. Lahousen Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA) Cancer 67 1991 1037 1045
45. L.J. Copeland, E.G. Silva, D.M. Gershenson Superficially invasive squamous cell carcinoma of the cervix Gynecol Oncol 45 1992 307 331
46. M. Newton Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow-up Am J Obstet Gynecol 123 1975 535 542
47. S.L. Buckley, D.M. Tritz, L. Van Le Lymph node metastases and prognosis in patients with stage IA2 cervical cancer Gynecol Oncol 63 1996 4 9
48. M.A. Finan, S. DeCesare, J.V. Fiorica Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix Does the new staging system predict morbidity and survival? Gynecol Oncol 62 1996 139 147
49. F. Landoni, A. Maneo, A. Colombo Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer Lancet 350 1997 535 540
50. D.A. Grisaru, A. Covens, E. Franssen Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-1B1-2 cervical carcinoma Cancer 97 2003 1904 1908
51. C.J. Wang, C.H. Lai, H.J. Huang Recurrent cervical carcinoma after primary radical surgery Am J Obstet Gynecol 181 1999 518 524
52. A. Ansink, A. de Barros Lopes, R. Naik Recurrent stage IB cervical carcinoma:evaluation of the effectiveness of routine follow up surveillance Br J Obstet Gynaecol 103 1996 1156 1158
53. R.R. Million, F. Rutledge, G.H. Fletcher Stage IV carcinoma of the cervix with bladder invasion Am J Obstet Gynecol 113 1972 239 246
54. P.J. Deckers, A.S. Ketcham, E.V. Sugerbaker Pelvic exenteration for primary carcinoma of the uterine cervix Obstet Gynecol 37 1971 647 659
55. S.K. Upadhyay, R.P. Symonds, M. Haelterman The treatment of stage IV carcinoma by radical dose radiotherapy Radiother Oncol 11 1988 15 19
56. V. Ratanatharathorn, W.E. Powers, N. Steverson Bone metastasis from cervical cancer Cancer 73 1994 2372 2379
57. R.Y. Kim, B. Weppelmann, M.M. Salter Skeletal metastases from cancer of the uterine cervix Frequency, patterns, and radiotherapeutic significance Int J Radiat Oncol Biol Phys 13 1987 705 708
58. T. Saphner, H.H. Gallion, J.R. Van Nagell Neurologic complications of cervical cancer Cancer 64 1989 1147 1151
59. G. Cormio, A. Pellegrino, F. Landoni Brain metastases from cervical carcinoma Tumori 82 1996 394 396
60. W.R. Robinson, L.I. Muderspach Case report Spinal cord compression in metastatic cervical cancer Gynecol Oncol 48 1993 269 271
61. W.T. Creasman, R.J. Zaino, F.J. Major Early invasive carcinoma of the cervix (3 to 5 mm invasion) Risk factors and prognosis Am J Obstet Gynecol 178 1998 62 65
62. G.M. Thomas Adjuvant therapy after primary surgery for stage I-IIA carcinoma of the cervix J Natl Cancer Inst Monogr 21 1996 77 83
63. J.J. Jobsen, J.W.H. Lee, F.J. Cleton Treatment of locoregional recurrence of carcinoma of the cervix by radiotherapy after primary surgery Gynecol Oncol 33 1989 368 371
64. D.M. Larson, L.J. Copeland, C.A. Stringer Recurrent cervical carcinoma after radical hysterectomy Gynecol Oncol 30 1988 381 387
65. M. Deutsch, J.A. Parson Radiotherapy for carcinoma of the cervix recurrent after surgery Cancer 34 1974 2051 2055
66. H. Ito, N. Shigematsu, T. Kawada Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy Gynecol Oncol 67 1997 154 161
67. R. Estape, R. Angioli Surgical management of advanced and recurrent cervical cancer Semin Surg Oncol 16 1999 236 241
68. G.W. Morley Pelvic exenterative therapy and the treatment of recurrent carcinoma of the cervix Semin Oncol 9 1982 331 340
69. F.Y. Durance, G.H. Fletcher, F.N. Rutledge Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus Am J Roentgenol Radium Ther Nucl Med 106 1969 831-388
70. S. Michalas, A. Rodolakis, Z. Voulgaris Management of early-stage cervical carcinoma by modified (type II) radical hysterectomy Gynecol Oncol 85 2002 415 422
71. A. Sedlis, B.N. Bundy, M.Z. Rotman A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy A Gynecology Oncology Group study Gynecol Oncol 73 1999 177 183
72. B. Sevin, M. Nadji, B. Lampe Prognostic factors of early stage cervical cancer treated by radical hysterectomy Cancer 76 1995 1978 1986
73. G. Delgado, B. Bundy, R. Zaino Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix A Gynecology Oncology Group study Gynecol Oncol 38 1990 352 357
74. R. Estape, R. Angioli, M. Madrigal Close vaginal margins as a prognostic factor after radical hysterectomy Gynecol Oncol 68 1998 229 231
75. M. Okada, J. Kigawa, Y. Minagawa Indication and efficacy of radiation therapy following surgery in patients with stage IB to IIA cervical cancer Gynecol Oncol 70 1998 61 64
76. G. Atkover, O. Uzel, M. Ozsahin Postoperative radiotherapy in carcinoma of the cervix treatment results and prognostic factors Radiother Oncol 35 1995 198 205
77. Y.N. Lee, K.L. Wang, M.H. Lin Radical hysterectomy with pelvic node dissection for treatment of cervical cancer A clinical review of 954 cases Gynecol Oncol 32 1989 135 142
78. R.R. Million, F. Rutledge, G.H. Fletcher Stage IV carcinoma of the cervix with bladder invasion Am J Obstet Gynecol 113 1972 239 245
79. P.J. Deckers, A.S. Ketcham, E.V. Sugerbaker Pelvic exenteration for primary carcinoma of the uterine cervix Obstet Gynecol 37 1971 647 659
80. H. Chou, C. Wang, C. Lai Isolated para-aortic lymph node recurrence after definitive irradiation for cervical carcinoma Int J Radiat Oncol Biol Phys 51 2001 442 448
81. A.B. Hill Reflection on controlled trial Ann Rheumatic Dis 25 1966 107 113
82. A.R. Feinstein Strategy of comparison in cause-effect research A.R. Feinstein Clinical epidemiology The architecture of clinical research 1985 WB Saunders Philadelphia 215 236
83. L. Barbera, J. Zhang-Salomons, J. Huang Defining the need for radiotherapy for lung cancer in the general population A criterion-based, benchmarking approach Med Care 41 2003 1074 1085
84. C.W. Whitney, W. Sause, B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-arotic lymph nodes A Gynecology Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
85. M. Morris, P.J. Eifel, J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
86. P.G. Rose, B.N. Bundy, E.B. Watkings Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
87. H.M. Keys, B.N. Bundy, F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
88. W.A. Peters, P.Y. Liu, R.T. Barrett Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
89. L. Barbera, H. Walker, F. Foroudi Estimating the benefit and cost of radiotherapy for lung cancer Int J Tech Assessment Health Care 20 2004 1 7